← All organizations
Highest phase reached
Phase 4
Timeline
1980s
- Jan 1, 1986
PharmaMar— Founded
Drugs by trial phase (45 distinct, 97 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (12 own, 0 via acquisition)
Indications
Studied for
- Acute Disease
- Adenocarcinoma
- Adnexal Diseases
- Aggression
- Bone Neoplasms
- Breast Diseases
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Chondrosarcoma
- Chondrosarcoma, Mesenchymal
- Colorectal Neoplasms
- DNA Repair-Deficiency Disorders
- Dry Eye Syndromes
- Endocrine Gland Neoplasms
- Endometrial Neoplasms
- Eye Diseases
- Eye Pain
- Fallopian Tube Neoplasms
- Genital Diseases, Female
- Genital Neoplasms, Female
- Glaucoma
- Glaucoma, Open-Angle
- Hepatic Insufficiency
- Hypertension
- Immunoblastic Lymphadenopathy
- Keratoconjunctivitis Sicca
- Leiomyosarcoma
- Leukemia
- Liposarcoma
- Liposarcoma, Myxoid
- Liver Failure
- Lung Neoplasms
- Lymphoma
- Lymphoma, Non-Hodgkin
- Lymphoma, T-Cell
- Mesothelioma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasm Metastasis
- Neoplasms
- Neoplasms by Histologic Type
- Neoplasms by Site
- Neoplasms, Connective and Soft Tissue
- Neoplasms, Plasma Cell
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Neuroectodermal Tumors, Primitive, Peripheral
- Neuroendocrine Tumors
- Ocular Hypertension
- Ovarian Diseases
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Peritoneal Neoplasms
- Preleukemia
- Primary Myelofibrosis
- Prostatic Neoplasms
- Sarcoma
- Sarcoma, Ewing
- Sarcoma, Synovial
- Skin Diseases
- Small Cell Lung Carcinoma
- Urogenital Neoplasms
- Uterine Cervical Neoplasms
- Uterine Neoplasms
Recent trials (50)
- NCT04291937Lead sponsorN/A—
- NCT06766825CollaboratorPhase 2Feb 7, 2025
- NCT06524583CollaboratorPhase 2Oct 31, 2024
- NCT06088290Lead sponsorPhase 2/Phase 3Sep 21, 2023
- NCT05572476CollaboratorPhase 2Apr 30, 2023
- NCT05841563Lead sponsorPhase 1Apr 28, 2023
- NCT05705167Lead sponsorPhase 2Apr 19, 2023
- NCT05835609Lead sponsorPhase 1Dec 23, 2022
- NCT05637255Lead sponsorPhase 2Nov 22, 2022
- NCT05310422Lead sponsorPhase 3Mar 24, 2022
- NCT05153239Lead sponsorPhase 3Jan 31, 2022
- NCT05121740Lead sponsorPhase 1/Phase 2Dec 13, 2021
- NCT04784559Overall official - principal investigatorPhase 3Jun 4, 2021
- NCT04784559Lead sponsorPhase 3Jun 4, 2021
- NCT04819269Lead sponsorPhase 3May 25, 2021
Details
- Founded
- Madrid, ES Jan 1, 1986
- Last known activity
- Feb 7, 2025